In the world of fat activism, the “O-words” – overweight and obesity – are expressly verboten. That’s because advocates and ...

A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...

Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions of dollars in lawsuits and growing concerns about long-term safety. Human ...

Medications like Ozempic mimic the GLP-1 hormone, so the user feels fuller for longer and doesn’t crave food as often.

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

With the price of weight-loss injection Mounjaro rising by 170 per cent next month, we asked a pharmacist and medical ...

According to a report by the Financial Times, Morgan & Morgan, a law firm, revealed it had filed a case on behalf of a ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

Four weeks after starting Mounjaro, Clare Meadowcroft was hospitalised for 10 days with acute pancreatitis and underwent ...

This is but a fact that obesity drugs are only going to get more accessible for Indians post March 2026. But whether they make us healthier depends on how we use them. If they become another ...

Scientists test OKV-119, a six-month implant dubbed 'Ozempup', as a new Ozempic for pets to fight obesity in cats and dogs amid rising pet health risks.